Q32 Bio Inc. (QTTB) Revenue History
Annual and quarterly revenue from 2016 to present
QTTB Revenue Over Time (2016–2025)
QTTB Revenue Growth History
3 of 6 years with positive growth- FY2016 revenue growth
- N/A
- FY2017 revenue growth
- N/A
- FY2018 revenue growth
- N/A
- FY2019 revenue growth
- -68.7%
- FY2020 revenue growth
- +62.2%
- FY2021 revenue growth
- +1157.3%
- FY2022 revenue growth
- -80.4%
- FY2023 revenue growth
- -200.0%
- FY2024 revenue growth
- +100.0%
- FY2025 revenue growth
- N/A
| Quarter | Revenue | YoY |
|---|---|---|
| Q1 2026 | $0 | — |
| Q4 2025 | $53.7M | — |
| Q3 2025 | $0 | — |
| Q2 2025 | $0 | — |
| Q1 2025 | $0 | — |
| Q4 2024 | $0 | +100.0% |
| Q3 2024 | $0 | -100.0% |
| Q2 2024 | $0 | -100.0% |
Multi-year avg. share of annual revenue by fiscal quarter
QTTB Revenue Analysis (2016–2025)
Current Revenue & Growth
As of June 12, 2026, Q32 Bio Inc. (QTTB) generated trailing twelve-month (TTM) revenue of $53.7 million. The most recent quarter (Q1 2026) recorded $0 in revenue, down 100.0% sequentially.
Historical Growth Trajectory
QTTB's 5-year compound annual growth rate (CAGR) stands at +81.9%, indicating outstanding long-term growth trajectory. The 3-year CAGR of +100.7% exceeds the 5-year average, indicating an acceleration in the most recent period. Q32 Bio Inc.'s highest annual revenue of $53.7 million was recorded in 2025, an all-time high.
Peer Comparison
Compared to Healthcare sector peers — including ARQT (+95.3% YoY). Compare QTTB vs ARQT →
QTTB Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
 QTTBCurrent | $54M | - | +81.9% | 31.5% | |
 ARQT | $376M | +95.3% | - | -3.3% |
QTTB Historical Revenue Data (2016–2025)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $53.7M | - | $53.3M | 99.3% | $16.9M | 31.5% |
| 2024 | $0 | +100.0% | $-487,000 | - | $-66,102,000 | - |
| 2023 | $-6,651,000 | -200.0% | $-6,651,000 | 100.0% | $-48,255,000 | 725.5% |
| 2022 | $6.7M | -80.4% | $6.7M | 100.0% | $-39,225,000 | -589.8% |
| 2021 | $34.0M | +1157.3% | $24.4M | 71.9% | $-95,949,000 | -282.4% |
| 2020 | $2.7M | +62.2% | $2.7M | 100.0% | $-130,263,000 | -4821.0% |
| 2019 | $1.7M | -68.7% | $1.7M | 100.0% | $-109,943,000 | -6599.2% |
| 2018 | $5.3M | - | $5.3M | 100.0% | $-59,926,000 | -1126.0% |
| 2017 | $0 | - | $-684,214 | - | $-29,657,500 | - |
| 2016 | $0 | - | $-239,797 | - | $-10,000,020 | - |
What if you invested $1,000 in QTTB back in 2016?
Total return with dividends reinvested · 10+ years of data
Calculate ReturnsHow much would $100/month in QTTB be worth today?
Dollar cost averaging vs lump sum · see how regular investing compounds over time
Run the NumbersIs QTTB Undervalued Right Now?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationQTTB vs LLY — which is the better buy?
Side-by-side revenue, margins, P/E and 10-year returns vs Eli Lilly and Company.
Compare NowQTTB — Frequently Asked Questions
Quick answers to the most common questions about buying QTTB stock.
Is QTTB's revenue growth accelerating or slowing?
QTTB TTM revenue: $54M. YoY growth: N/A. 5-year CAGR: +81.9%.
What is QTTB's revenue history from 2016 to 2026?
Q32 Bio Inc. (QTTB) revenue history spans 2016 to 2026. TTM revenue as of 2026 is $54M, growing at N/A YoY. The 5-year CAGR is +81.9%. Complete annual and quarterly revenue figures are available on this page, including gross profit, operating income, and margin trends.
What is QTTB's long-term revenue growth rate (CAGR)?
Q32 Bio Inc.'s 5-year revenue CAGR of +81.9% reflects the variable nature of its business expansion. As of 2026, the current YoY growth rate of N/A is in line with this long-term average. CAGR is the most reliable measure of sustained revenue momentum for QTTB.
Why does QTTB's quarterly revenue fluctuate?
QTTB quarterly revenue can fluctuate significantly between periods. A quarter-over-quarter (QoQ) change does not always indicate a trend; comparing the same quarter year-over-year (YoY) is a more reliable signal for underlying growth. Q32 Bio Inc.'s revenue data from 2016 to 2026 shows full historical quarterly detail on this page.
How is QTTB's revenue distributed by segment?
QTTB reports revenue broken down by product line and geographic region. The segment breakdown on this page shows which business units contribute the most to total revenue as of the latest fiscal year. Concentration in a single segment above 50% indicates category dependence, while a diversified mix signals more resilient revenue streams.
How does QTTB's revenue compare to industry peers?
Q32 Bio Inc. (QTTB) with TTM revenue of $54M and N/A YoY growth can be benchmarked against sector peers using the comparison table on this page. Revenue growth relative to peers indicates market share gains or losses. The peer section shows TTM revenue, YoY growth, and operating margin for direct comparisons.